Guardant Health (GH) News Today

State Board of Administration of Florida Retirement System increased its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 254.0% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 114,125 sh

Edgestream Partners L.P. boosted its position in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 376.3% in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 46,939 shares of the company's stock after purchasi

Guardant Health, Inc. (NASDAQ:GH - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2024 earnings per share estimates for shares of Guardant Health in a report issued on Thursday, July 18th. Leerink Partnrs analyst P. Souda now forecasts that the company will post earnings of

Shares of Guardant Health, Inc. (NASDAQ:GH - Get Free Report) have received an average recommendation of "Moderate Buy" from the fifteen research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold rating and fourte

Bank of America lifted their price objective on shares of Guardant Health from $28.00 to $40.00 and gave the company a "buy" rating in a research report on Thursday.

Duality Advisers LP bought a new stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 55,952 shares of the company's stock, valued at approximately $1,154,000. Several other hedge funds have also

Guardant Health (NASDAQ:GH) Trading Up 9.9%

Guardant Health (NASDAQ:GH) Trading Down 2.9%

Baillie Gifford & Co. grew its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 0.9% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 6,232,104 shares of the company's stock after purchasing an additional 53,292 shares du

Vanguard Group Inc. raised its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 1.6% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 11,130,654 shares of the company's stock after buying an additional

Guggenheim raised shares of Guardant Health from a "neutral" rating to a "buy" rating and set a $36.00 price objective on the stock in a research note on Friday.

Wellington Management Group LLP raised its holdings in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 24.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 834,084 shares of the company's stock after purchas

Guardant Health, Inc. (NASDAQ:GH - Get Free Report) has received a consensus rating of "Moderate Buy" from the fourteen ratings firms that are presently covering the company, MarketBeat reports. Two investment analysts have rated the stock with a hold recommendation and twelve have assigned a buy

Teachers Retirement System of The State of Kentucky purchased a new stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm purchased 142,986 shares of the company's stock, valued at approximately

Blue Water Life Science Advisors LP trimmed its position in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 15.5% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 571,047 shares of the company's stock after sell

First Light Asset Management LLC decreased its stake in shares of Guardant Health, Inc. (NASDAQ:GH - Free Report) by 27.5% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 144,049 shares of the company's stock after

Cadian Capital Management LP bought a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 710,000 shares of the company's stock, valued at approximately $19,206,000. Guardant Health comprises a

Capital International Investors grew its holdings in Guardant Health, Inc. (NASDAQ:GH - Free Report) by 36.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 4,001,803 shares of the company's stock after purchasing an additional 1,074,452 shar

Guardant Health (NASDAQ:GH) Trading Down 6.1%

Guardant Health (NASDAQ:GH) Shares Up 7.3% on Analyst Upgrade

Canaccord Genuity Group boosted their price objective on Guardant Health from $30.00 to $38.00 and gave the stock a "buy" rating in a report on Tuesday.

Guardant Health, Inc. (NASDAQ:GH - Get Free Report) was the recipient of a significant growth in short interest in May. As of May 15th, there was short interest totalling 10,760,000 shares, a growth of 5.9% from the April 30th total of 10,160,000 shares. Based on an average daily trading volume, of 2,270,000 shares, the short-interest ratio is presently 4.7 days.

Jefferies Financial Group initiated coverage on shares of Guardant Health in a report on Monday. They issued a "buy" rating and a $32.00 price objective for the company.

Norges Bank bought a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 943,433 shares of the company's stock, valued at approximately $25,520,

Guardant Health, Inc. (NASDAQ:GH - Free Report) - Equities researchers at Leerink Partnrs decreased their FY2024 EPS estimates for Guardant Health in a research report issued to clients and investors on Tuesday, May 28th. Leerink Partnrs analyst P. Souda now anticipates that the company will post

Eaton Financial Holdings Company LLC purchased a new stake in Guardant Health, Inc. (NASDAQ:GH - Free Report) in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm purchased 80,707 shares of the company's stock, valued at approximately $2

Stephens restated an "overweight" rating and issued a $44.00 target price on shares of Guardant Health in a research note on Friday.

Guardant Health (NASDAQ:GH) Shares Gap Up to $22.51